MRK.F Merck & Company Inc

Healthcare Pharmaceuticals Frankfurt Exchange
497.38 EUR
Close of Nov 13, 2026
98.67 155.10
Market cap
EUR 64.3B
P/E
27.1x
P/B
2.18x
ROE
7.6%
Dividend yield
0.44%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MRK.F undervalued?

Graham number
Price497.38
Graham value306.82
Premium62.1%

MRK.F trades 62.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Merck & Company Inc fundamental analysis

No fundamental analysis for Merck & Company Inc yet.

Merck & Company Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Merck & Company Inc

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomo…

Full company profile